Hints and tips:
...Before Alere, Mr Nawana spent more than 15 years at Johnson & Johnson, including time as president of its DePuy Synthes spine business....
...Medical devices, however, declined 4.8 per cent to $5.9bn as elective and non-essential procedures relating to surgery, orthopaedics and other fields were pushed back to free up healthcare service capacity...
...Still, orthopaedics is largely a consolidation story. DePuy Synthes was created following Johnson & Johnson’s $21.3bn takeover of Switzerland’s Synthes in 2012....
...Actually, maybe add the orthopaedic cost from hauling said rucksack around too? Not that Tesla hasn't been at this sort of thing before....
...Smith & Nephew, another Elliott target, jumped to a five-month high amid a retread of takeover speculation around the orthopaedic devices maker....
...The verdict includes $1bn in punitive damages against J&J and DePuy, a subsidiary, as well as $30m in actual damages for the plaintiffs, according to Mark Lanier, the lead attorney for the plaintiffs....
...The cuts equate to roughly 6 per cent of the company’s medical devices workforce, and will be heaviest in the orthopaedics division, which makes hip replacements, as well as its surgical and cardiovascular...
...S&N added 1.8 per cent to £11.65 on talk of interest from Johnson & Johnson, whose DePuy orthopaedic subsidiary was pushed to number three in the market for knee implants by Zimmer’s purchase of Biomet....
...A number of clinician-led clinics are also growing, such as one by Fortius, a specialist in orthopaedic and sports injuries....
...For all the talk of diversification, much still depends on S&N’s ability to compete in orthopaedics....
...The recession has made life even tougher for the family, says Mr Mendes Machado, who earns a commission from selling orthopaedic mattresses....
...common applications currently involve the creation of implants used in surgery on the face and jaw, particularly when reconstruction is needed due to congenital conditions or trauma, and in cardiac and orthopaedic...
...Both were arrested and Ms Dhada’s uncle’s orthopaedic clinic was vandalised by Shiv Sena supporters....
...Another theory doing the rounds was that J&J could carve up S&N and spin out its DePuy orthopaedics division into the UK listing as a way to minimise tax....
...Orthopaedics maker Smith & Nephew edged 0.3 per cent lower at 871.5p after weaker than expected earnings from Johnson & Johnson’s competing division, Global DePuy....
...The orthopaedic device maker spiked on Thursday, rising as much as 6.8 per cent to hit an intraday high, on a newswire report that US peer Medtronic was evaluating a takeover offer....
...Mr Bohuon’s comments come a week after Indiana-based Zimmer, maker of the eponymous walking frame, agreed to buy orthopaedic products group Biomet for $13bn....
...Stryker’s statement came as Smith & Nephew’s share price rose 17 per cent after the Financial Times reported that the US orthopaedic products group was working on a bid....
...Johnson & Johnson has agreed to pay $2.5bn to settle claims from 8,000 US patients who used artificial hips made by its medical devices subsidiary DuPuy Orthopaedics....
...It found that HCA accounted for more than 60 per cent of private cancer care, orthopaedics, obstetrics and gynaecology, and gastrointestinal medicine in the capital....
...The company took unspecified litigation charges, against a backdrop of continuing legal actions including compensation demands from users of its DePuy ASR artificial hip....
...Mallinath Kini was an orthopaedic surgeon but increasingly felt his “career values” had changed. He found he became more interested in the business side of the National Health Service....
...(Financial Times) Johnson & Johnson has agreed to pay $2.5bn to settle claims from 8,000 US patients who used artificial hips made by its medical devices subsidiary DuPuy Orthopaedics....
...Listed competitors, Stryker Corp in the US and UK-based Smith & Nephew, Europe’s largest orthopaedic device maker, are valued at about 8.5 times ebitda, which would give Biomet a theoretical valuation of...
International Edition